Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach

被引:26
|
作者
Costantini, Susan [1 ]
Raucci, Raffaele [2 ]
De Vero, Teresa [2 ]
Castello, Giuseppe [1 ]
Colonna, Giovanni [2 ]
机构
[1] IRCCS, Fdn Giovanni Pascale, Ist Nazl Studio & Cura Tumori, I-83013 Mercogliano, AV, Italy
[2] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy
关键词
CXCR3; CXCR4; CXCR7; CXCL11; CXCL12; PROTEIN; CHEMOKINES; CANCER; RECOGNITION; BINDING; INFLAMMATION; ANTAGONISTS; DOCKING; VARIANT; GROWTH;
D O I
10.1016/j.cyto.2013.05.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokine receptor trio composed by CXCR3, CXCR4 and CXCR7 represents a hard and interesting challenge for cancer biology because these three receptors are found to be over-expressed in different cancers as well as to bind the same chemokines. In fact, CXCR4 interacts with CXCL12, CXCR7 not only with CXCL12 but also with CXCL11, that is a natural ligand for CXCR3. For these reasons, it seems necessary to define and to identify the structural determinants of CXCR3, CXCR4 and CXCR7 and their related physic-chemical properties that permit them to bind CXCL11 and CXCL12. Hence in this paper we show the modeling of CXCR7 and its complex with CXCL11 and CXCL12 compared to CXCR3/CXCL11 and CXCR4/CXCL12. Our results show that (i) CXCR3, CXCR4 and CXCR7 present similar trans-membrane helices and different conformations of N-terminal and C-terminal regions as well as of three extracellular loops, and (ii) the predominant interaction between the three receptors and the two chemokines are on hydrophobic and electrostatic basis. Moreover, our data confirm that CXCL12 binds to CXCR7 with higher affinity than to CXCR4. Methodologically, we can also conclude that our computational strategy is adequate to model correctly the interactions between these chemokines and their receptors; therefore, our models represent a good structural basis to design and develop peptides able to block contemporaneously CXCR3, CXCR4 and CXCR7 receptor trio. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:316 / 321
页数:6
相关论文
共 50 条
  • [1] Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12
    Singh, Anup Kumar
    Arya, Rakesh Kumar
    Trivedi, Arun Kumar
    Sanyal, Sabyasachi
    Baral, Rathindranath
    Dormond, Olivier
    Briscoe, David M.
    Datta, Dipak
    CYTOKINE & GROWTH FACTOR REVIEWS, 2013, 24 (01) : 41 - 49
  • [2] CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
    Naumann, Ulrike
    Cameroni, Elisabetta
    Pruenster, Monika
    Mahabaleshwar, Harsha
    Raz, Erez
    Zerwes, Hans-Guenter
    Rot, Antal
    Thelen, Marcus
    PLOS ONE, 2010, 5 (02):
  • [3] Differential beta-3 integrin of CXCR3, CXCR4, and CXCR7 clustering on breast cancer cells in response to CXCL11, CXCL12, and Adrenomedullin
    Mosley, LaSharon Denise
    Sharma, Praveen K.
    Singh, Rajesh
    Singh, Shailesh
    Lillard, James W., Jr.
    FASEB JOURNAL, 2008, 22
  • [4] CXCR7, CXCR4 and CXCL12: An eccentric trio?
    Thelen, Marcus
    Thelen, Sylvia
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 198 (1-2) : 9 - 13
  • [5] CXCL11 and CXCL12 activates ERK1/2 and NF-kB in breast cancer cells via CXCR3, CXCR4 and CXCR7
    Mosley, Lasharon D.
    Singh, Rajesh
    Sharma, Praveen K.
    Singh, Shailesh
    Lillard, James W., Jr.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [6] CXCL12, CXCR4 and CXCR7 Expression in brain metastases
    Salmaggi, Andrea
    Maderna, Emanuela
    Calatozzolo, Chiara
    Gaviani, Paola
    Canazza, Alessandra
    Milanesi, Ida
    Antonio, Silvani
    DiMeco, Francesco
    Carbone, Antonino
    Pollo, Bianca
    CANCER BIOLOGY & THERAPY, 2009, 8 (17) : 1615 - 1621
  • [7] Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7
    Goita, Aissata Aimee
    Guenot, Dominique
    CANCERS, 2022, 14 (07)
  • [8] CXCL11 and CXCL12 modulate ERK1/2 and NF-kB activation in breast cancer cells via CXCR3, CXCR4, and CXCR7
    Mosley, Lasharon
    Singh, Rajesh
    Sharma, Praveen
    Singh, Shailesh
    Lillard, James
    CANCER RESEARCH, 2009, 69
  • [9] Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory Bowel Disease
    Werner, Lael
    Guzner-Gur, Hanan
    Dotan, Iris
    THERANOSTICS, 2013, 3 (01): : 40 - 46
  • [10] CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7
    Puchert, Malte
    Obst, Jessica
    Koch, Christian
    Zieger, Konstanze
    Engele, Juergen
    CYTOKINE, 2020, 125